At maximum doses, retatrutide has higher rates of nausea (43% vs 31%), vomiting (21% vs 12%), diarrhea (33% vs 23%), and constipation (25% vs 11%) compared to tirzepatide
This means no hidden fillers, no synthetic binders, and a relentless focus on sourcing the highest quality ingredients
The peptide upregulates growth hormone receptors on tendon fibroblasts, enhances neurotrophic factor expression, and promotes angiogenesis through the VEGFR2-Akt-eNOS signaling pathway
Huberman emphasizes that while peptides show potential, they should be approached cautiously and used under professional supervision
MS in Exercise Physiology from the University of Alabama (Tuscaloosa, AL)